Principal Scientist - Bioanalytical Outsourcing
Regeneron Pharmaceuticals
Summary
Bioanalytical Outsourcing Team
Job description
Experienced – Principal Scientist, Bioanalytical Outsourcing
Bioanalytical Outsourcing Team
Build our future together
We are seeking a highly motivated Principal Scientist to join our Bioanalytical Outsourcing Team (BOT). As Principal Scientist in the BOT, you will be responsible for overseeing all bioanalysis of PK, Immunogenicity, and biomarkers (nonclinical and clinical) at external CROs, including management of assay development/qualification/validation efforts on various analytical platforms as well as the subsequent sample analysis and reporting efforts for each drug program. You will be responsible for communicating status and progress on these deliverables to the appropriate stakeholders. The successful candidate will have demonstrated technical proficiency, solid understanding of the GLPs and GCLPs, exhibit scientific rigor and independent thought as well as the ability to thrive in a team-oriented environment.
Discover your role
- Provide scientific and operational oversight on all aspects of bioanalytical activities conducted at Contract Research Organizations (CROs), independently and in collaboration with representatives of the Bioanalytical Outsourcing Team.
- Provide CRO with critical material, obtain needed documentation, work with CRO to reconcile any scientific or operational concerns, manage standing review meetings, arrange vendor visits as appropriate.
- Provide scientific support to CRO efforts in design, development, and implementation of a variety of analytical methods in a regulated (GLP, GCLP) environment and ensure that these activities are in line with current regulatory guidelines.
- Work with internal and external SMEs (Subject Matter Experts) to address any/all issues that may occur during assay development and/or sample analysis.
- Interface with CROs to ensure on time delivery of required milestones and proactively communicate with the CRO to ensure transparency and adherence to the timelines, availability of required contracts, quotes, purchase orders etc.
- Reviewing sample analysis of pharmacokinetic, immunogenicity, and biomarkers from nonclinical studies, as well as bioanalytical data to ensure the quality and integrity of data.
This role requires
- Previous experience in managing external CROs in assay validation and bioanalysis.
- Strong communication skills and the ability to efficiently work in a cross-functional environment.
- Ability to work under tight timelines and be flexible with changing priorities.
- Ability to think creatively and strategically with strong problem-solving and multi-tasking skills.
- Hands-on experience with regulated bioanalysis including assay validation/qualification under multiple platforms: LBA, LC/MS, PCR-based methods.
- A Ph.D. with 10+ years of experience in the Pharmaceutical Industry.
- Preferred: Experience with novel drug candidates (gene therapies, CAR-T, ADCs, AOCs, etc).
Requirements
- Previous experience in managing external CROs in assay validation and bioanalysis
- Strong communication skills and ability to work in a cross-functional environment
- Ability to work under tight timelines and be flexible with changing priorities
- Ability to think creatively and strategically with strong problem-solving and multi-tasking skills
- Hands-on experience with regulated bioanalysis including assay validation/qualification under multiple platforms: LBA, LC/MS, PCR-based methods
- Ph.D. with 10+ years of experience in the Pharmaceutical Industry
- Preferred: Experience with novel drug candidates (gene therapies, CAR-T, ADCs, AOCs, etc)
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Matching
- Health and Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Life & Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.